On 2 May 2018, the Inland Revenue (Amendment) (No. 3) Bill 2018 (“the Bill”; click here) was introduced into the Legislative Council. This bill provides enhanced tax deductions for certain expenses incurred in relation to research and development (“R&D”) activities.
The Bill contains safeguards to prevent the abuse of tax deductions in respect of R&D activities. It also deems certain sums to be trading receipts and thus chargeable to tax.
Currently, any R&D expenditure incurred by a taxpayer related to its business qualifies for a 100% tax deduction, subject to certain conditions. The R&D expenditure must be incurred in respect of R&D activities undertaken by the taxpayer itself or paid to an approved research institution.
The enhanced R&D tax incentive will commence from the year of assessment 2018/19. There are transitional provisions for payments incurred before the date of enactment.
Consistent with international experience with R&D incentives, the Bill contains relatively complex provisions which define the relevant R&D activities. To this end, a new Schedule 45 deals with qualifying R&D activities and introduces two new types of R&D expenditures (Type A and Type B).
New Section 16B and Schedule 45
The new Section 16B of the Inland Revenue Ordinance provides for (i) deduction of expenditures on R&D activities; and (ii) taxability of the proceeds of sale of plant or machinery for, and rights generated from, R&D activities. Schedule 45 provides definitions and operational details for the calculation of the deduction and income from any sale.
The Bill proposes classifying R&D expenditure into two broad categories (Type A and Type B expenditures) which are deductible subject to meeting certain conditions. Type A qualifies for a basic 100% tax deduction. It is Type B expenditure that qualifies for the enhanced two-tiered tax deduction (300% tax deduction for the first HKD2 million and 200% for the remaining amount).
Where Type A expenditure is incurred for an R&D activity performed outside or partly outside Hong Kong, the deduction for the expenditure is subject to apportionment. By contrast, Type B expenditure will qualify for enhanced tax deduction only if the relevant R&D activity is wholly carried out in Hong Kong.
Qualifying R&D activity
The critical element to qualify for Type B expenditure is that the R&D activity is wholly undertaken in Hong Kong and meets one of the following conditions:
However, the Bill excludes certain activities from qualifying as Type B expenditure through a series of somewhat vague definitions. Excluded activities include:
Qualifying R&D expenditure
In order for expenditure on a qualifying R&D activity to be deductible, it must be incurred in relation to the taxpayer’s business and must be:
Again, there are some key exclusions where no R&D deduction is allowed. This includes where the R&D expenditure is undertaken for another person, any rights generated from the R&D activity are not fully vested in the person, or the costs are met by the government or another person.
Deemed taxable trading receipts
The Bill also includes deeming provisions. Where proceeds are earned from the sale of plant or machinery for, or rights generated from, an R&D activity for which the capital expenditure has been allowed as a deduction, such proceeds will be taxable (but limited to the amount of deduction previously allowed).
Also, certain receipts (such as royalties received for the use or right to use outside Hong Kong of any intellectual property or know-how generated from any R&D activity for which the capital expenditure has been allowed as a deduction) will be treated as taxable income.
Other miscellaneous matters
Where an R&D claim or an advance ruling application is made by a taxpayer, the Commission of Inland Revenue (“CIR”) may seek advice from the Commissioner for Innovation & Technology (“CI&T”) to ascertain whether: (i) an activity is a qualifying R&D activity; and (ii) a R&D expenditure was incurred in relation to a R&D activity or a qualifying R&D activity.
The CIR may disclose details to the CI&T during the consultation. However, it is the CIR who makes the final decision as to whether the R&D expenditure is deductible.
This is another welcome tax incentive that will provide Hong Kong with a competitive advantage in promoting R&D activities to be carried out in Hong Kong. Not surprisingly, with a particularly generous R&D deduction, there are onerous and complex conditions that need to be satisfied in order to qualify for an enhanced tax deduction.
In our experience, many companies will find that they are conducting quality R&D activities as part of their product and process improvement activities. To ensure that they are in a position to claim the new benefit, it will be vital that they have the systems and processes in place to correctly identify projects and classify their R&D expenditure.
Furthermore, as the Inland Revenue Department (“IRD”) has the ultimate discretion to determine whether the R&D expenditure incurred is deductible, in practice, the IRD’s attitude towards allowing R&D claims will be an important factor in enabling taxpayers to access enhanced deductions. In some countries, overzealous tax authorities have effectively gutted these type of regimes. Finding the right balance is crucial to the success of the new regime.
For more information and assistance, please contact your usual tax advisor or one of our tax advisors below.
© 2020 KPMG Huazhen LLP — a People's Republic of China partnership, KPMG Advisory (China) Limited — a wholly foreign owned enterprise in China, and KPMG — a Hong Kong partnership, are member firms of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved. The KPMG name and logo are registered trademarks or trademarks of KPMG International.
Save what resonates, curate a library of information, and share content with your network of contacts.
You've been a member since